Cargando…
Identification of Tumor Antigens and Immune Subtypes for the Development of mRNA Vaccines and Individualized Immunotherapy in Soft Tissue Sarcoma
SIMPLE SUMMARY: Soft tissue sarcomas (STS) are a group of rare malignant tumors with high tissue heterogeneity and poor prognosis, and which are still without effective individualized immunotherapy approaches. In this study, four potential tumor antigens, six STS immune subtypes, and six functional...
Autores principales: | Wu, Changwu, Duan, Yingjuan, Gong, Siming, Osterhoff, Georg, Kallendrusch, Sonja, Schopow, Nikolas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8774220/ https://www.ncbi.nlm.nih.gov/pubmed/35053609 http://dx.doi.org/10.3390/cancers14020448 |
Ejemplares similares
-
PLOD Family: A Novel Biomarker for Prognosis and Personalized Treatment in Soft Tissue Sarcoma
por: Gong, Siming, et al.
Publicado: (2022) -
A Human Pan-Cancer System Analysis of Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase 3 (PLOD3)
por: Gong, Siming, et al.
Publicado: (2021) -
Integrative and Comprehensive Pancancer Analysis of Regulator of Chromatin Condensation 1 (RCC1)
por: Wu, Changwu, et al.
Publicado: (2021) -
A Novel Four-Gene Prognostic Signature for Prediction of Survival in Patients with Soft Tissue Sarcoma
por: Wu, Changwu, et al.
Publicado: (2021) -
A tumor microenvironment-based prognostic index for osteosarcoma
por: Wu, Changwu, et al.
Publicado: (2023)